Search
for
Sort by
Research 61–90 of 166
- Antitumor Activities of the Typhonium flagelliforme Extract Combined with Natural Interferons of Canine and Feline in Mice with DMBA Induced Skin Tumors
- Hair Changes due to Drugs
- Subject Index
- Index
- Global Research Trends for Platelet-Rich Plasma: A Science Mapping with Machine Learning Techniques
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Nilontinib induced keratosis pilaris atrophicans
- Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
- Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma
- Oral isotretinoin therapy and milia formation in patients with acne vulgaris: A prospective study
- WARFARIN
- The JAK/STAT signaling pathway: from bench to clinic
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Actinic keratosis: a clinical and epidemiological revision
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi’s Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Intelligent nanotherapeutic strategies for the delivery of CRISPR system
- Topical delivery of nanoemulsions for skin cancer treatment
- Targeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments
- MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022